Ascendis Pharma A/S (id:7370 ASND)
139.70 USD
Opening hours: 09:30 - 16:00 (Eastern Standard Time: 12/24/2024 7:28:37 AM)
Exchange closed, opens in 2 hours 1 minutes
1.98 USD (1.98%)
3.00 USD (3.00%)
17.41 USD (17.41%)
2.96 USD (2.96%)
11.56 USD (11.56%)
3.14 USD (3.14%)
549.77 USD (549.77%)
About Ascendis Pharma A/S
Market Capitalization 8.24B
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapies for unmet medical needs. It offers SKYTROFA for treating patients with growth hormone deficiency (GHD). The company is also developing a pipeline of three independent endocrinology rare disease product candidates in clinical development, as well as focuses on advancing oncology therapeutic candidates. The company was incorporated in 2006 and is headquartered in Hellerup, Denmark.
| Headquarters (address) |
Tuborg Boulevard 12 Hellerup 2900 Denmark |
| Phone | 45 70 22 22 44 |
| Website | https://ascendispharma.com |
| Employees | 879 |
| Sector | Healthcare |
| Industry | Biotechnology |
| Ticker | ASND |
| Exchange | NASDAQ Stock Exchange |
| Currency | USD |
| 52 week range | 111.09 - 161.00 |
| Market Capitalization | 8.24B |
| P/E trailing | -15.95 |
| P/E forward | -34.87 |
| Price/Sale | 25.93 |
| Price/Book | -77.31 |
| Beta | 3.00 |
| EPS | -7.82 |
| EPS Denmark (ID:148, base:8) | 5.00 |